Consistent neurodegeneration and its association with clinical progression in huntington's disease: A coordinate-based meta-analysis

Neurodegenerative Diseases

Volumn 12, Issue 1, 2013, Pages 23-35

  Dogan, Imis ^a,b,c   Eickhoff, Simon B ^b,d   Schulz, Jörg B ^a,c   Shah, N Jon ^a,b,c   Laird, Angela R ^e   Fox, Peter T ^e   Reetz, Kathrin ^a,b,c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

^c Translational Brain Medicine   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Anatomical likelihood estimation; Atrophy; Huntington's disease; Meta analysis; Neurodegeneration; Voxel based morphometry

Indexed keywords

AMYGDALOID NUCLEUS; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN DEGENERATION; CAG REPEAT; CINGULATE GYRUS; DISEASE COURSE; FRONTAL CORTEX; GENE MUTATION; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; INSULA; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL CORTEX; PREMOTOR CORTEX; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSORIMOTOR CORTEX; SYSTEMATIC REVIEW; TEMPORAL CORTEX; THALAMUS; VOXEL BASED MORPHOMETRY; BRAIN REGION; CLINICAL FEATURE; META ANALYSIS; MOTOR DYSFUNCTION; NERVE DEGENERATION;

ATROPHY; BRAIN; DISEASE PROGRESSION; FEMALE; HUMANS; HUNTINGTON DISEASE; LIKELIHOOD FUNCTIONS; MAGNETIC RESONANCE IMAGING; MALE; NERVE DEGENERATION;

ADENOSINE; CYTOSINE; GUANOSINE;

EID: 84879416006     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000339528     Document Type: Article

References (54)

1. The Huntington's Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971-983
2. Aylward EH, Sparks BF, Field KM, Yallapragada V, Shpritz BD, Rosenblatt A, Brandt J, Gourley LM, Liang K, Zhou H, Margolis RL, Ross CA: Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 2004; 63: 66-72
3. Paulsen JS, Nopoulos PC, Aylward E, Ross CA, Johnson H, Magnotta VA, Juhl A, Pierson RK, Mills J, Langbehn D, Nance M; PREDICT- HD Investigators and Coordinators of the Huntington's Study Group (HSG): Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull 2010; 82: 201-207
4. Bohanna I, Georgiou-Karistianis N, Hannan AJ, Egan GF: Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease. Brain Res Rev 2008; 58: 209-225
5. Paulsen JS, Hayden M, Stout JC, Langbehn DR, Aylward E, Ross CA, Guttman M, Nance M, Kieburtz K, Oakes D, Shoulson I, Kayson E, Johnson S, Penziner E: Preparing for preventive clinical trials: the Predict-HD study. Arch Neurol 2006; 63: 883-890
6. Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, Landwehrmeyer B, Stout JC: Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009; 8: 791-801
7. Harris GJ, Codori AM, Lewis RF, Schmidt E, Bedi A, Brandt J: Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. Brain 1999; 122: 1667-1678
8. Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC: Brain structure in preclinical Huntington's disease. Biol Psychiatry 2006; 59: 57-63
9. van den Bogaard SJ, Dumas EM, Acharya TP, Johnson H, Langbehn DR, Scahill RI, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA: Early atrophy of pallidum and accumbens nucleus in Huntington's disease. J Neurol 2011; 258: 412-420
10. Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B: Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 2005; 65: 745-747
11. Nopoulos PC, Aylward EH, Ross CA, Johnson HJ, Magnotta VA, Juhl AR, Pierson RK, Mills J, Langbehn DR, Paulsen JS; PREDICT- HD Investigators Coordinators of Huntington Study Group (HSG): Cerebral cortex structure in prodromal Huntington disease. Neurobiol Dis 2010; 40: 544-554
12. Ashburner J, Friston KJ: Voxel-based morphometry - the methods. Neuroimage 2000; 11: 805-821
13. Douaud G, Gaura V, Ribeiro MJ, Lethimonnier F, Maroy R, Verny C, Krystkowiak P, Damier P, Bachoud-Levi AC, Hantraye P, Remy P: Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage 2006; 32: 1562-1575
14. Klöppel S, Chu C, Tan GC, Draganski B, Johnson H, Paulsen JS, Kienzle W, Tabrizi SJ, Ashburner J, Frackowiak RS: Automatic detection of preclinical neurodegeneration: presymptomatic Huntington disease. Neurology 2009; 72: 426-431
15. Klöppel S, Stonnington CM, Petrovic P, Mobbs D, Tuscher O, Craufurd D, Tabrizi SJ, Frackowiak RS: Irritability in pre-clinical Huntington's disease. Neuropsychologia 2010; 48: 549-557
16. Stoffers D, Sheldon S, Kuperman JM, Goldstein J, Corey-Bloom J, Aron AR: Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study. Neurology 2010; 74: 1208-1216
17. Wolf RC, Vasic N, Schonfeldt-Lecuona C, Landwehrmeyer GB, Ecker D: Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain 2007; 130: 2845- 2857
18. Gavazzi C, Nave RD, Petralli R, Rocca MA, Guerrini L, Tessa C, Diciotti S, Filippi M, Piacentini S, Mascalchi M: Combining functional and structural brain magnetic resonance imaging in Huntington disease. J Comput Assist Tomogr 2007; 31: 574-580
19. Gomez-Anson B, Alegret M, Munoz E, Monte GC, Alayrach E, Sanchez A, Boada M, Tolosa E: Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number. Parkinsonism Relat Disord 2009; 15: 213-219
20. Henley SM, Wild EJ, Hobbs NZ, Scahill RI, Ridgway GR, Macmanus DG, Barker RA, Fox NC, Tabrizi SJ: Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. J Neurol 2009; 256: 203-212
21. Ille R, Schafer A, Scharmuller W, Enzinger C, Schoggl H, Kapfhammer HP, Schienle A: Emotion recognition and experience in Huntington disease: a voxel-based morphometry study. J Psychiatry Neurosci 2011; 36: 383-390
22. Kassubek J, Juengling FD, Kioschies T, Henkel K, Karitzky J, Kramer B, Ecker D, Andrich J, Saft C, Kraus P, Aschoff AJ, Ludolph AC, Landwehrmeyer GB: Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry 2004; 75: 213-220
23. Mühlau M, Weindl A, Wohlschlager AM, Gaser C, Stadtler M, Valet M, Zimmer C, Kassubek J, Peinemann A: Voxel-based morphometry indicates relative preservation of the limbic prefrontal cortex in early Huntington disease. J Neural Transm 2007; 114: 367-372
24. Nave RD, Ginestroni A, Tessa C, Giannelli M, Piacentini S, Filippi M, Mascalchi M: Regional distribution and clinical correlates of white matter structural damage in Huntington disease: a tract-based spatial statistics study. AJNR Am J Neuroradiol 2010; 31: 1675-1681
25. Peinemann A, Schuller S, Pohl C, Jahn T, Weindl A, Kassubek J: Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study. J Neurol Sci 2005; 239: 11- 19
26. Thieben MJ, Duggins AJ, Good CD, Gomes L, Mahant N, Richards F, McCusker E, Frackowiak RS: The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 2002; 125: 1815- 1828
27. Wolf RC, Vasic N, Schonfeldt-Lecuona C, Ecker D, Landwehrmeyer GB: Cortical dysfunction in patients with Huntington's disease during working memory performance. Hum Brain Mapp 2009; 30: 327-339
28. Zimbelman JL, Paulsen JS, Mikos A, Reynolds NC, Hoffmann RG, Rao SM: fMRI detection of early neural dysfunction in preclinical Huntington's disease. J Int Neuropsychol Soc 2007; 13: 758-769
29. Shoulson I, Fahn S: Huntington disease: clinical care and evaluation. Neurology 1979; 29: 1-3
30. Eickhoff SB, Laird AR, Grefkes C, Wang LE, Zilles K, Fox PT: Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: a random-effects approach based on empirical estimates of spatial uncertainty. Hum Brain Mapp 2009; 30: 2907-2926
31. Turkeltaub PE, Eden GF, Jones KM, Zeffiro TA: Meta-analysis of the functional neuroanatomy of single-word reading: method and validation. Neuroimage 2002; 16: 765- 780
32. Turkeltaub PE, Eickhoff SB, Laird AR, Fox M, Wiener M, Fox P: Minimizing within-experiment and within-group effects in activation likelihood estimation meta-analyses. Hum Brain Mapp 2012; 33: 1-13
33. Schroeter ML, Raczka K, Neumann J, Yves von Cramon D: Towards a nosology for frontotemporal lobar degenerations - a metaanalysis involving 267 subjects. Neuroimage 2007; 36: 497-510
34. Schroeter ML, Raczka K, Neumann J, von Cramon DY: Neural networks in frontotemporal dementia - a meta-analysis. Neurobiol Aging 2008; 29: 418-426
35. Glahn DC, Laird AR, Ellison-Wright I, Thelen SM, Robinson JL, Lancaster JL, Bullmore E, Fox PT: Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 2008; 64: 774-781
36. Nichols T, Brett M, Andersson J, Wager T, Poline JB: Valid conjunction inference with the minimum statistic. Neuroimage 2005; 25: 653-660
37. Caspers S, Zilles K, Laird AR, Eickhoff SB: ALE meta-analysis of action observation and imitation in the human brain. Neuroimage 2010; 50: 1148-1167
38. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, Zilles K: A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 2005; 25: 1325-1335
39. Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH: CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 1997; 41: 689-692
40. Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR: A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004; 65: 267-277
41. Behrens TE, Johansen-Berg H, Woolrich MW, Smith SM, Wheeler-Kingshott CA, Boulby PA, Barker GJ, Sillery EL, Sheehan K, Ciccarelli O, Thompson AJ, Brady JM, Matthews PM: Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci 2003; 6: 750-757
42. Kassubek J, Juengling FD, Ecker D, Landwehrmeyer GB: Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis. Cereb Cortex 2005; 15: 846-853
43. Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, Greve D, Hevelone N, Hersch SM: Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008; 131: 1057-1068
44. Bohanna I, Georgiou-Karistianis N, Egan GF: Connectivity-based segmentation of the striatum in Huntington's disease: vulnerability of motor pathways. Neurobiol Dis 2011; 42: 475-481
45. Eickhoff SB, Jbabdi S, Caspers S, Laird AR, Fox PT, Zilles K, Behrens TE: Anatomical and functional connectivity of cytoarchitectonic areas within the human parietal operculum. J Neurosci 2010; 30: 6409-6421
46. Alexander GE, DeLong MR, Strick PL: Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357-381
47. Hobbs NZ, Pedrick AV, Say MJ, Frost C, Dar Santos R, Coleman A, Sturrock A, Craufurd D, Stout JC, Leavitt BR, Barnes J, Tabrizi SJ, Scahill RI: The structural involvement of the cingulate cortex in premanifest and early Huntington's disease. Mov Disord 2011; 26: 1684-1690
48. Thu DC, Oorschot DE, Tippett LJ, Nana AL, Hogg VM, Synek BJ, Luthi-Carter R, Waldvogel HJ, Faull RL: Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Brain 2010; 133: 1094-1110
49. Eickhoff SB, Heim S, Zilles K, Amunts K: A systems perspective on the effective connectivity of overt speech production. Philos Transact A Math Phys Eng Sci 2009; 367: 2399-2421
50. Culham JC, Cavina-Pratesi C, Singhal A: The role of parietal cortex in visuomotor control: what have we learned from neuroimaging? Neuropsychologia 2006; 44: 2668- 2684
51. Rupp J, Dzemidzic M, Blekher T, West J, Hui S, Wojcieszek J, Saykin AJ, Kareken DA, Foroud T: Comparison of vertical and horizontal saccade measures and their relation to gray matter changes in premanifest and manifest Huntington disease. J Neurol 2012; 259: 267-276
52. Kipps CM, Duggins AJ, McCusker EA, Calder AJ: Disgust and happiness recognition correlate with anteroventral insula and amygdala volume respectively in preclinical Huntington's disease. J Cogn Neurosci 2007; 19: 1206-1217
53. Rosas HD, Reuter M, Doros G, Lee SY, Triggs T, Malarick K, Fischl B, Salat DH, Hersch SM: A tale of two factors: what determines the rate of progression in Huntington's disease? A longitudinal MRI study. Mov Disord 2011; 26: 1691-1697
54. Mühlau M, Gaser C, Wohlschlager AM, Weindl A, Stadtler M, Valet M, Zimmer C, Kassubek J, Peinemann A: Striatal gray matter loss in Huntington's disease is leftward biased. Mov Disord 2007; 22: 116-1173.